PAGANI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 2.392
EU - Europa 1.652
AS - Asia 1.375
SA - Sud America 10
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.440
Nazione #
US - Stati Uniti d'America 2.356
CN - Cina 1.252
IE - Irlanda 489
UA - Ucraina 377
FI - Finlandia 250
DE - Germania 201
SE - Svezia 113
IT - Italia 110
SG - Singapore 102
GB - Regno Unito 57
CA - Canada 36
FR - Francia 34
BE - Belgio 9
BR - Brasile 8
AU - Australia 7
JP - Giappone 4
MY - Malesia 4
NL - Olanda 4
VN - Vietnam 4
CZ - Repubblica Ceca 3
EU - Europa 3
HK - Hong Kong 2
HU - Ungheria 2
IN - India 2
RU - Federazione Russa 2
TR - Turchia 2
VE - Venezuela 2
ES - Italia 1
IQ - Iraq 1
LB - Libano 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 5.440
Città #
Jacksonville 492
Dublin 488
Chandler 460
Nanjing 378
Boardman 156
Nanchang 151
Ashburn 139
Beijing 119
Hebei 116
Wilmington 111
Princeton 109
Lawrence 106
Medford 105
Shenyang 99
Changsha 95
Jiaxing 90
Ann Arbor 64
Singapore 59
Tianjin 59
Helsinki 50
Hangzhou 40
Dearborn 33
Toronto 32
New York 31
Milan 26
Verona 22
Woodbridge 21
Seattle 19
Shanghai 19
Pavia 17
Kunming 14
Norwalk 14
Brussels 9
Fairfield 9
Jinan 8
Des Moines 7
Guangzhou 7
Lanzhou 7
Taizhou 7
Los Angeles 6
Ningbo 6
Zhengzhou 6
Houston 5
San Francisco 5
Canberra 4
Dong Ket 4
Falls Church 4
Tokyo 4
Turin 4
Brno 3
Chicago 3
Dallas 3
Melbourne 3
Munich 3
Orange 3
Acireale 2
Caracas 2
Changchun 2
Cosenza 2
Costa Mesa 2
Foggia 2
Fredericksburg 2
Fuzhou 2
Redmond 2
Rio de Janeiro 2
Rome 2
Tappahannock 2
Washington 2
Altoona 1
Amsterdam 1
Auburn Hills 1
Baghdad 1
Baotou 1
Brugherio 1
Budapest 1
Buffalo 1
Cambridge 1
Central 1
Chieti 1
Chongqing 1
Christchurch 1
Donegal 1
Easton 1
Falkenstein 1
Fayetteville 1
Giarre 1
Haikou 1
Hong Kong 1
Jinhua 1
Kingston 1
London 1
Nanning 1
Newark 1
Pompano Beach 1
Radcliffe 1
Recife 1
Riyadh 1
Santa Clara 1
Santarcangelo 1
Santo André 1
Totale 3.912
Nome #
3-M syndrome associated with growth hormone deficiency: 18 year follow-up of a patient. 85
Growth Hormone Receptor Gene Expression in Puberty. 82
Analysis of growth hormone receptor gene expression in idiopathic tall stature children. 80
Human lymphocytes as a model for evaluating growth hormone (GH) action in normal and Laron syndrome children 78
Prevelenza dell'associazione del deficit di ormone della crescita (GH) e della celiachia in bambini di bassa statura 75
Ormone della crescita e sistema immunitario 73
Changes in adiponectin and leptin circulating levels during the first year of life in neonates 73
The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year's growth response in GH-deficient children. 72
Abnormal GH receptor signalling and partial GH resistence in a patient with idiopathic short stature 72
Adherence to growth hormone therapy: a practical approach. 71
Accrescimento staturale ed altezza definitiva in bambini con deficit di GH e celiachia 71
Adipokine profile in growth hormone deficient (GHD) children before and after GH treatment 71
A 5.8 Mb interstitial deletion on chromosome Xq21.1 in a boy with intellectual disability, cleft palate, hearing impairment and combined growth hormone deficiency 71
Changes in circulating levels of adiponectin and leptin in children during the first two years of life 70
Variations in biological and immunological activity of growth hormone during the neonatal period. 70
Approccio diagnostico alla bassa statura 69
Development of antibodies against growth hormone (GH) during rhGH therapy in a girl with idiopathic GH deficiency: a case report. 69
Effetto dell'ormone della crescita (GH) sui livelli sierici di citochine 67
I ridotti livelli circolanti di IGF-I e GHBP nei bambini pigmei Babinga correlano con la loro bassa statura 66
Human amniotic fluid cells are able to produce IL-6 and IL-8. 65
Changes in growth hormone receptor gene expression during therapy in children with juvenile idiopathic arthritis 65
Biologia molecolare. Il modello del recettore per il GH 65
Diagnosi differenziale tra la sindrome di Bierich e la sindrome di Laron: ruolo del metodo di dosaggio dell'IGF-I 64
Serum IGF-I and IGFBP-3 reference values from a chemiluminescent assay in normal children and adolescents of Hispanic and Italian origin: presence of a sexual dimorphism in IGF-I values 63
Development of a novel bioassay for evaluating growth hormone (GH) bioactivity 63
Common adipokine features of neonates and centenarians 63
Association of the (CA)(n) repeat polymorphism of Insulin-like-Growth Factor-I (IGF-I) and -202 A/C IGF Binding Protein-3 (IGFBP3) Promoter Polymorphism with Adult height in patients with severe growth hormone deficiency. 63
Unreliability of classic provocative tests for the diagnosis of growth hormone deficiency 63
Serum cytokine levels in GH-deficient children during substitutive GH therapy 62
Unreliability of classic provocative tests for the diagnosis of growth hormone deficiency. 62
Stimulating effect of growth hormone on cytokine release in children 62
A Case of Craniopharyngioma Presenting as Precocious Puberty after a Period of Stunted Growth 62
Growth hormone system and immune function 60
Syndrome of GH bioinactivity: myth or reality? 60
Different Long-Term Response to Growth Hormone Therapy in Small- versus Appropriate-for-Gestational-Age Children with Growth Hormone Deficiency. 60
The influence of long-term GH therapy on cytokine release in GHD children 59
Kinetics of the nuclear traslocation of Stat-5b in immortalized normal control lymphocytes, as studied by immunocytochemistry. Sexual dimorphism of the growth hormone receptor signalling pathway response to rhGH 59
Can growth hormone deficiency diagnosis be affected by the GH immunoassay used? 58
Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders 57
Growth hormone receptor exon 6 isophorms influence GH response to dynamic stimulation 57
Breast feeding: gamut of benefits. 57
Growth hormone isoforms release in response to physiological and pharmacological stimuli. 56
Is BaF3 bioassay useful to identify patients with bioinactive growth hormone? 56
Changes in growth hormone receptor gene expression during therapy in children with juvenile idiopathic arthritis. 56
Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment. 55
Circulating GH isoforms and GH bioactivity in preterm neonates. 55
Development of antibodies against growth hormone (GH) during rhGH therapy in a girl with idiopathic GH deficiency: a case report. 55
Celiac disease and short stature in children. 55
Secular trends in growth of African Pygmies and Bantu 54
Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling 53
Growth factors evaluation in Babinga Pygmy from childhood to adulthood 53
Biochemical analysis of muscle biopsy in overnight fasting patients with severe chronic heart failure 53
The Pygmy short stature enigma 52
Reference ranges for serum IGF-I and IGFBP-3 by a chemiluminescent assay in children and adolescents. Sexual dimorphism in IGF-I values 52
Diagnosis of growth hormone (GH) deficiency is affected by calibrators used in GH immunoassays. 52
Late diagnosis of celiac disease in an asymptomatic infant with growth failure 52
Response to long-term growth hormone therapy in short children with reduced GH bioactivity. 51
Effect of human recombinant growth hormone therapy on circulating levels of erythropoietin and granulocyte-colony stimulating factor in short stature 51
Heterozygous GHR gene mutation in a child with idiopathic short stature 51
Hormona del crecimiento biologicamente inactiva 50
Patient with bioinactive growth hormone (GH): growth responce at the 1st year of GH therapy 50
Prevalenza dell'associazione del deficit di ormone della crescita (GH) e della celiachia in bambini di bassa statura 49
Decreased IGF-I and GHBP circulating levels in Babinga Pygmy children correlate with their stunted growth 49
Analysis of growth hormone receptor gene expression in tall and short stature children 49
Effects of growth hormone on natural killer cells 48
Short stature in children with coeliac disease 48
Do celiac children with growth hormone deficiency treated with growth hormone (GH) reach normal final height? 48
Relationship between the endocrine and immune system: reality or mith? 48
GH secretory pattern in non-obese children and adolescents with Prader-Willi sindrome 48
Effect of growth hormone therapy on the proinflammatory cytokine profile in growth hormone-deficient children. 47
Relationship between growth hormone (GH) and the immune system: Myth or realtiy? 47
Identification of autophagy-related genes and their regulatory miRNAs associated with celiac disease in children 47
Effect of human recombinant growth hormone therapy on circulating levels of erythropoietin and granulocyte colony stimulating factor in chort children 47
Kinetics of the nuclear traslocation of STAT-5b in immortalized normal control lymphocytes, as studied by immunocytochemistry 46
The shortness of Pygmies is associated with severe under-expression of the growth hormone receptor 46
Efficacy of long-term growth hormone therapy in short non-growth hormone-deficient children 45
Can growth hormone (GH) therapy affect the humoral system in GH-deficient children? 45
Indagine conoscitiva sugli interventi organici in corso da parte di istituzioni pediatriche italiane a favore dell'assistenza pediatrica dei paesi in via di sviluppo 45
Growth failure in pediatric tubercular meninigitis. 44
Growth retardation in children with celiac disease 43
Growth hormone immunoreactivity does not reflect bioactivity. 42
Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome 42
Dose dependency of the serum bio/immuno GH ratio in children during pharmacological secretion tests. 42
Clinical management of short children with low serum immunoglobulin but no immunodeficiency features 41
Different growth pattern in response to GH therapy in SGA and AGA GH-deficient prepubertal children 40
Omitting duodenal biopsy in children with suspected celiac disease and extra-intestinal symptoms 40
Role of adiponectin and leptin on body development in infants during the first year of life 37
Effect of growth hormone (GH) on the immune system 37
Tall stature: A difficult diagnosis? 37
Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. 37
Difetti molecolari nell'asse GH/IGF-I. Ruolo del recettore dell'ormone della crescita 36
Hyperimmunoglobulinaemia in Babinga Pygmies is present from infancy 36
Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12 month GH treatment. 35
Heterozygous GHR gene mutation in a child with idiopathic short stature. 34
Variations of growth hormone (GH) isoforms during the early postnatal life. 34
Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency Endocrinology 34
Common adipokine features of neonates and centenarians 32
Growth hormone receptor polymorphisms and growth hormone response to stimulation test: a pilot study 32
Respuesta de la hormona de crecimiento (GH) bioactiva sérica a test farmacológicos. Dosis dependencia de la relación bio/inmuno de la GH sérica 31
Is retesting in growth hormone deficient children really useful? 28
Totale 5.412
Categoria #
all - tutte 22.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020422 0 0 0 0 4 85 10 113 6 169 31 4
2020/2021650 85 59 13 73 2 82 4 104 14 106 89 19
2021/2022466 3 5 28 1 7 29 3 20 35 3 68 264
2022/20231.382 163 95 8 110 142 145 0 93 564 11 37 14
2023/2024428 52 67 10 40 53 131 6 30 1 7 11 20
2024/2025253 20 121 34 44 34 0 0 0 0 0 0 0
Totale 5.566